You are here » Home » Companies » Company Overview » Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd.

BSE: 532305 Sector: Health care
NSE: INDSWFTLAB ISIN Code: INE915B01019
BSE 15:40 | 19 Jan 64.00 0.35
(0.55%)
OPEN

61.85

HIGH

65.00

LOW

61.75

NSE 15:31 | 19 Jan 63.65 -0.45
(-0.70%)
OPEN

64.00

HIGH

65.50

LOW

62.10

OPEN 61.85
PREVIOUS CLOSE 63.65
VOLUME 10174
52-Week high 83.50
52-Week low 31.00
P/E
Mkt Cap.(Rs cr) 290
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 61.85
CLOSE 63.65
VOLUME 10174
52-Week high 83.50
52-Week low 31.00
P/E
Mkt Cap.(Rs cr) 290
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Ind-Swift Laboratories Ltd. (INDSWFTLAB) - Company Information

Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India. The company manufactures and sells active pharmaceutical ingredients (API). Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (a...> More

COMPANY INFORMATION
Director : Gopal Munjal
Vice Chairman & M.D. : N R Munjal
Chairman : S R Mehta
Director : V R Mehta
Joint Managing Director : Himanshu Jain
Independent Director : K M S Nambiar
Independent Director : J K Kakkar
Company Secretary : Pradeep Verma
Executive Director : Rishav Mehta
Nominee (SBI) : S V Singh
Independent Director : Ashwani Kumar Vig
Independent Director : Prabhat Khurana
Independent Director : Preetika Chaubey
Independent Director : S P Sharma
AUDITOR : Avishkar Singhal & Associates/Jain & Associates
IND NAME : Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME : Indian Private
Registered office
SCO 850 Shivalik Enclave, NAC Manimajra,Chandigarh,Chandigarh-160101
Ph : 91-0172-5061850/2730920
WEBSITE : http://www.indswiftlabs.com
E-mail : investor@indswiftlabs.com